Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Yilmaz Ozyazgan"'
Autor:
Didar Ucar, Burak Mergen, Busenur Gonen, Yesim Ozguler, Emire Seyahi, Vedat Hamuryudan, Yilmaz Ozyazgan
Publikováno v:
Indian Journal of Ophthalmology, Vol 68, Iss 9, Pp 1876-1880 (2020)
Purpose: To compare the long-term results of the patients with branch retinal vein occlusion (BRVO) secondary to Behçet's syndrome (BS) with the patients with unknown etiology. Methods: Medical records and optical coherence tomography (OCT) imaging
Externí odkaz:
https://doaj.org/article/f5f7f581ed354c09bde2a5dfff00ad8e
Autor:
F. Nilüfer Yalçındağ, Ilknur Tugal-Tutkun, Yilmaz Ozyazgan, Pinar Cakar Ozdal, Figen Batıoğlu
Publikováno v:
Turkish Journal of Ophthalmology
Türk Oftalmoloji Dergisi, Vol 51, Iss 4, Pp 206-211 (2021)
Türk Oftalmoloji Dergisi, Vol 51, Iss 4, Pp 206-211 (2021)
Objectives: To analyze and compare sociodemographic features between Behcet uveitis and other non-infectious uveitis. Materials and Methods: The data of adults with non-infectious uveitis in the nationwide uveitis database were analyzed and the socio
Autor:
Vedat Hamuryudan, Emire Seyahi, Busenur Gonen, Yesim Ozguler, Yilmaz Ozyazgan, Didar Ucar, Burak Mergen
Publikováno v:
Indian Journal of Ophthalmology
Indian Journal of Ophthalmology, Vol 68, Iss 9, Pp 1876-1880 (2020)
Indian Journal of Ophthalmology, Vol 68, Iss 9, Pp 1876-1880 (2020)
Purpose: To compare the long-term results of the patients with branch retinal vein occlusion (BRVO) secondary to Behcet's syndrome (BS) with the patients with unknown etiology. Methods: Medical records and optical coherence tomography (OCT) imaging r
Autor:
Yilmaz Ozyazgan, Merih Oray, Fatime Nilüfer Yalçındağ, Sibel Kadayifcilar, Rajesh Vedhanayaki, Maarten Boers, Mehmet Akman, Esra Kardes, Moncef Khairallah, Yonca A. Akova, Sivakumar R. Rathinam, Ilknur Tugal-Tutkun, Radgonde Amer, Ahmet Gül, Pinar Cakar Ozdal, Sumru Onal, Cigdem Altan, Berna Basarir, Jos W. R. Twisk, Miles Stanford
Publikováno v:
Tugal-Tutkun, I, Onal, S, Stanford, M, Akman, M, Twisk, J W R, Boers, M, Oray, M, Özdal, P Ç, Kadayifcilar, S, Amer, R, Rathinam, S R, Vedhanayaki, R, Khairallah, M, Akova, Y, Yalcindag, F N, Kardes, E, Basarir, B, Altan, Ç, Özyazgan, Y & Gül, A 2021, ' An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults ', Ocular Immunology and Inflammation, pp. 1-10 . https://doi.org/10.1080/09273948.2020.1736310
Ocular Immunology and Inflammation, 1-10. Taylor and Francis Ltd.
STARTPAGE=1;ENDPAGE=10;ISSN=0927-3948;TITLE=Ocular Immunology and Inflammation
Ocular Immunology and Inflammation, 1-10. Taylor and Francis Ltd.
STARTPAGE=1;ENDPAGE=10;ISSN=0927-3948;TITLE=Ocular Immunology and Inflammation
Purpose: To develop an algorithm for the diagnosis of Behçet's disease (BD) uveitis based on ocular findings.Methods: Following an initial survey among uveitis experts, we collected multi-center retrospective data on 211 patients with BD uveitis and
Autor:
David Callanan, Michala Karkanová, Yenchieh Cheng, Karen Chu, Valerie Corp-dit-Genti, Marc D. de Smet, Jarmila Heissigerova, Yuhwen Soo, Robert Vitti, Rafael Varona, Namrata Saroj, Quan Dong Nguyen, Olga Garcia-Garcia, Sunil K. Srivastava, Erickson Kristine A, Yilmaz Ozyazgan, Ronald Buggage, P.A. Sundaram, Sibel Kadayifcilar, A. N. Athanikar
Publikováno v:
Ophthalmology. 126:428-437
Purpose To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU). Design Randomized, double-masked, placebo-controlled, phase 2 study. Participants Fifty-
Autor:
S. S. Taflan, Yesim Ozguler, Izzet Fresko, Zekayi Kutlubay, Gulen Hatemi, B. Tukek, Didar Ucar, Sinem Nihal Esatoglu, Ugur Uygunoglu, Melike Melikoglu, Halil Yazici, Vedat Hamuryudan, Aksel Siva, Emire Seyahi, Yilmaz Ozyazgan, Sebahattin Yurdakul
Publikováno v:
Annals of the Rheumatic Diseases. 80:660-661
Background:Infliximab (IFX) plays a key role in the management of severe and refractory manifestations of Behçet syndrome (BS). However we had previously shown that its sustained use may be limited due to adverse events and lack of patient complianc
Autor:
Marion R. Munk, Yan Guex-Crosier, Ilknur Tugal-Tutkun, Massimo Accorinti, J. Fernando Arevalo, Moncef Khairallah, Joyce Hisae Yamamoto, Avinash Gurbaxani, Zohar Habot-Wilner, Talin Barisani-Asenbauer, Justine R. Smith, Douglas A. Jabs, Mamta Agarwal, Stephen C. Teoh, Marie-Hélène Errera, Alastair K Denniston, Alex Fonollosa, Fatma Asyari, Digambar Behra, Ekaterina Denisova, Aera Kee, Debra A. Goldstein, Richard W J Lee, H. Nida Sen, Sudha K Ganesh, Peizeng Yang, Ariel Schlaen, Careen Y. Lowder, Rubens Belfort, Alan G. Palestine, Kalpana Babu, Sarakshi Mahajan, Aman Sharma, Radgonde Amer, Manisha Agarwal, Francesco Pichi, Peter McCluskey, Samir S. Shoughy, Soumyava Basu, Piergiorgio Neri, Manfred Zierhut, Dipankar Das, Annabelle A. Okada, Jyotirmay Biswas, Amitabh Kumar, Yilmaz Ozyazgan, John H. Kempen, Luca Cimino, Amod Gupta, Edoardo Baglivo, Rupesh Agrawal, Carlos Pavesio, Atul Kumar, Myhanh Nguyen, Salil Mehta, Saurabh Luthra, Kanika Aggarwal, Yonca A. Akova, Quan Dong Nguyen, Daniel Vitor Vasconcelos-Santos, Lucia Kuffova, Rina La Distia Nora, Harvey S. Uy, Maria Sofia Tognon, Jennifer E. Thorne, Romi Chhabra, Heloisa Nascimento, Cristina Muccioli, Justus G. Garweg, Mark Westcott, Christoph Tappeiner, D Makhoul, Onn Minn Kon, Ilaria Testi, Bulbul Islam Shah, Janet L. Davis, Arnd Heiligenhaus, Bahram Bodaghi, Ester Carreño, Vishali Gupta, Padmamalini Mahendradas, Aniruddha Agarwal, Alay S. Banker, Soon-Phaik Chee, Marc D. de Smet, Elisabetta Miserocchi, André Luiz Land Curi, Pinar Cakar Ozdal, Masoud Soheilian, Shelina Oli Mohamed, Alessandro Invernizzi
Publikováno v:
Ocular Immunology and Inflammation
Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB).Methods: Uveitis experts initially administered and further delib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95322889345dbace5264e92eea6f9c2
http://hdl.handle.net/1887/121084
http://hdl.handle.net/1887/121084
Autor:
Izzet Fresko, E. B. Caliskan, Yesim Ozguler, B. Tukek, Zekayi Kutlubay, Ugur Uygunoglu, Aksel Siva, Yilmaz Ozyazgan, Emire Seyahi, Sinem Nihal Esatoglu, Didar Ucar, Halil Yazici, Gulen Hatemi, S. Yurdakul, Melike Melikoglu, Vedat Hamuryudan
Publikováno v:
Annals of the Rheumatic Diseases. 80:662.2-663
Background:Infliximab (IFX) is increasingly used in the management of severe, relapsing or refractory manifestations of Behçet Syndrome (BS). Emergence of de novo manifestations have been reported during IFX treatment, despite efficacy for the initi
Autor:
Elaine F. Remmers, Ahmet Gül, Yohei Kirino, Sofia A. Oliveira, Fahmida Ghaderibarmi, Bahar Sadeghi Abdollahi, Daniel L. Kastner, Mary Blake, Masaki Takeuchi, Michael J. Ombrello, Nobuhisa Mizuki, Yilmaz Ozyazgan, Massimo Gadina, Fereydoun Davatchi, Atsuhisa Ueda, Burak Erer, Julie Le, Vânia Francisco, Ilknur Tugal-Tutkun, Abdolhadi Nadji, Niloofar Mojarad Shafiee, Akira Meguro, Colleen Satorius, Farhad Shahram, Tatsukata Kawagoe, Yoshiaki Ishigatsubo, Emire Seyahi, Shigeaki Ohno, Duran Ustek, Inês Sousa
Publikováno v:
Nature genetics
Daniel Kastner, Elaine Remmers and colleagues perform an association study of Behcet's disease based on dense genotyping of immune-related loci. They identify new association signals near genes involved in host response to microbial exposure and exte
Autor:
Elif, Dincses, Sinem Nihal, Esatoglu, Yesim, Ozguler, Ugur, Uygunoglu, Vedat, Hamuryudan, Emire, Seyahi, Melike, Melikoglu, Izzet, Fresko, Didar, Ucar, Yilmaz, Ozyazgan, Zekayi, Kutlubay, M Cem, Mat, Sebahattin, Yurdakul, Aksel, Siva, Gulen, Hatemi
Publikováno v:
Clinical and experimental rheumatology. 37(6)
The efficacy and safety of biosimilar infliximab (bio-IFX) was shown in randomised controlled trials and it was approved for all indications of the reference product in several countries. However, a previous case series of 3 patients with Behçet's s